[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Erleada- Drug Insight, 2019

July 2019 | 35 pages | ID: ECD09BBE666EN
DelveInsight

US$ 1,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 48 Hours

'Erleada - Drug Insight, 2019' report by DelveInsight provides comprehensive information of the drug, Erleada. It includes drugs overview, Erleada mechanism of action, clinical trials, regulatory milestones, deals & Erleada’s partnerships. It further provides Erleada`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted Erleada sales till 2021. The report also throws light on Erleada market competition and emerging therapies in the same space as Erleada. Erleada SWOT analysis is also featured. * Depending on information availability

METHODOLOGY

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

SCOPE OF THE REPORT
  • A comprehensive Erleada overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Erleada Patent information in United States (US) and Europe (EU) has been highlighted
  • Erleada API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Erleada sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Erleada operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Erleada SWOT analysis
REASONS TO BUY
  • Establish a comprehensive understanding of the drug, Erleada
  • Access to Erleada API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Erleada patents for the major markets- US and EU
  • Understand current and future Erleada`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Erleada
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Erleada
  • Identify opportunities in the same area as with Erleada SWOT analysis
1. REPORT INTRODUCTION

2. ERLEADA - OVERVIEW

Erleada Product Description
Erleada Route of Synthesis
Erleada Mechanism of Action
Erleada Pharmacology
Erleada Pharmacodynamics
Erleada Pharmacokinetics
Erleada Adverse Reactions
Erleada Clinical Trials
Erleada Regulatory Milestones
Erleada Development Activities

3. GLOBAL API MANUFACTURERS

United States
Europe
China
India

4. PRODUCT DETAILS

United States
Europe

5. ERLEADA GLOBAL SALES ASSESSMENT

Erleada Sales Global(Historical)
Erleada Sales Global(Forecasted)

6. ERLEADA PATENT DETAILS

7. ERLEADA MARKET COMPETITION

8. ERLEADA EMERGING THERAPIES

8.1. Drug name: Company name
Product Description
Research & Development
Product Development Activities
Other product profiles in the detailed report

9. ERLEADA SWOT ANALYSIS

Appendix
Methodology
Consulting Services
About DelveInsight

LIST OF TABLES

Table 1: Erleada, Description
Table 2: API Manufacturers Region wise
Table 3: API Manufacturers for United States
Table 4: API Manufacturers for Europe
Table 5: API Manufacturers for China
Table 6: API Manufacturers for India
Table 7: Erleada Product Details, United States
Table 8: Erleada Product Details, Europe
Table 9: Erleada, Historical Global Sales till 2017 (in million USD)
Table 10: Erleada, Forecasted Global Sales from 2019-2021 (in million USD)
Table 11: Patent Details: Erleada
Table 12: Erleada Major Competitors
Table 13: Emerging Therapies

LIST OF FIGURES

Figure 1: Erleada
Figure 2: Erleada, Historical Global Sales till 2017 (in million USD)
Figure 3: Erleada, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 4: Patent Details: Erleada
Figure 5: API Manufacturers Region wise


More Publications